OncoTargets and Therapy (Feb 2018)

Reversine, a substituted purine, exerts an inhibitive effect on human renal carcinoma cells via induction of cell apoptosis and polyploidy

  • Cheng L,
  • Wang H,
  • Guo KC,
  • Wang ZC,
  • Zhang ZY,
  • Shen C,
  • Chen L,
  • Lin J

Journal volume & issue
Vol. Volume 11
pp. 1025 – 1035

Abstract

Read online

Li Cheng,1,2,* Hao Wang,3,* Kecun Guo,4 Zicheng Wang,1,2 Zhongyuan Zhang,1,2,5 Cheng Shen,1,2,5 Liang Chen,6 Jian Lin1,2,5 1Department of Urology, Peking University First Hospital, Beijing, China; 2Institute of Urology, Peking University, Beijing, China; 3Department of Obstetrics and Gynecology, Peking University First Hospital, Beijing, China; 4Department of Urology, The Second People’s Hospital of Liaocheng, Shandong, China; 5National Urological Cancer Center, Beijing, China; 6Medical Center of Reproductive and Genetics, Peking University First Hospital, Beijing, China *These authors contributed equally to the paper Background: Human renal cell carcinoma (RCC) is the most common type of kidney cancer that arises from the renal epithelium. Up to 33.3% of RCC patients treated with local tumor resections will subsequently develop recurrence or metastases. Thus, optimized therapeutic regimes are urgently needed to improve the prognosis of RCC. Reversine was recently reported to exert critical roles in cancer therapy.Materials and methods: This study evaluated the anti-tumor effects of reversine on cell viability, colony formation, apoptosis, and cell cycle in 786-O and ACHN cell lines.Results: It was demonstrated that reversine significantly inhibited the proliferation of both cell lines in time- and dose-dependent manners. Polyploidy formation was observed under high-concentration reversine treatment. In addition, reversine induced cell death via caspase-dependent apoptotic pathways, which could be partially inhibited by Z-VAD-FMK, a pan-caspase inhibitor.Conclusion: Reversine could effectively suppress the proliferation of human RCC cells, and may serve as a novel therapeutic regimen for RCC in clinical practice. Keywords: anti-cancer, apoptosis, Aurora kinase, human renal cell carcinoma, polyploidy, reversine

Keywords